The company, based in Norcross, GA, manufactures more than 900 DNA and RNA isolation products used in clinical research, biotechnology, genomics, and agriculture.

Eli Lilly will shell out $2.4 billion to acquire genetic medicine developer Orna Therapeutics and has committed up to $8.85 billion to launch a seventh collaboration with Innovent Biologics. Both ...

A new study has found bacterial sugars that cause neurodegenerative immune response, providing a mechanism for therapeutic intervention.

"Successful automation depends on orchestration, not just robotics," notes Werner Maas, PhD, CEO, Hudson Lab Automation.

In this GEN webinar, Joshua Orchard, a purification applications scientist with extensive experience in downstream process development of various modalities, will share strategies and experimental ...